EyeGate Pharma to Proceed with PE Pivotal Study
Go back to EyeGate Pharma to Proceed with PE Pivotal Study| (NASDAQ: EYEG) | Delayed: 33.58 +0.07 (0.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $33.51 | 52 Week High | $5.09 | |||
| Open | $33.58 | 52 Week Low | $1.11 | |||
| Day High | $33.58 | P/E | N/A | |||
| Day Low | $33.54 | EPS | $0.00 | |||
| Volume | 44,322 | |||||



